Treatment of Allergic Dermatitis on the Face
For allergic dermatitis on the face, topical calcineurin inhibitors (TCIs) such as pimecrolimus 1% cream or tacrolimus 0.03% ointment are the first-line treatment due to their efficacy and lower risk of skin atrophy compared to topical corticosteroids. 1
Initial Assessment and Diagnosis
Determine the severity of facial allergic dermatitis:
- Mild: Limited areas, minimal impact on quality of life
- Moderate: More extensive involvement, moderate impact on quality of life
- Severe: Widespread involvement, significant impact on quality of life
Consider potential allergens:
Treatment Algorithm
First-Line Treatment
Topical Calcineurin Inhibitors (TCIs)
Low-Potency Topical Corticosteroids (Short-Term Only)
Supportive Measures
Allergen Identification and Avoidance
Skin Barrier Repair
For Persistent or Severe Cases
Consider systemic therapy if topical treatments fail:
- Oral antihistamines for pruritus control
- Short course of systemic corticosteroids for severe flares (with caution due to rebound risk) 1
Referral to dermatologist for:
Special Considerations for Facial Dermatitis
Periocular involvement:
- Review all eye medications as potential allergens 2
- TCIs are preferred over corticosteroids due to risk of glaucoma and cataracts with corticosteroids
Maintenance therapy:
Treatment Efficacy and Monitoring
- Expect improvement within 1-2 weeks with appropriate treatment
- If no improvement after 2 weeks, reconsider diagnosis and potential unidentified allergens
- Monitor for:
- Resolution of erythema, scaling, and pruritus
- Adverse effects from medications
- New potential allergen exposures
Common Pitfalls to Avoid
- Using medium or high-potency topical corticosteroids on facial skin
- Prolonged use of even low-potency corticosteroids on the face
- Failure to identify and eliminate causative allergens
- Inadequate patient education about allergen avoidance
- Overlooking occupational and environmental triggers
By following this treatment approach, most cases of allergic dermatitis on the face can be effectively managed with minimal risk of adverse effects.